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DETRUSOR SMOOTH MUSCLE (DSM), which makes up the bladder wall, relaxes during bladder filling and contracts phasically during voiding (2) . The underlying cause of the spontaneous phasic DSM contractions is the spontaneous action potential and corresponding Ca 2ϩ transients (19 -22, 25-27, 47) . Initiation of the action potential in guinea pig DSM arises from the opening of L-type voltage-gated Ca 2ϩ channels followed by an increase in the intracellular Ca 2ϩ concentration (25) . The repolarization phase of the DSM action potential is initiated by activation of large-conductance Ca 2ϩ -activated K ϩ (BK) channels, voltage-gated K ϩ (K V ) channels (56) , and negative feedback Ca 2ϩ -mediated inhibition of the L-type voltage-gated Ca 2ϩ channels (7, 11, 19, 26, 35, 46, 48) , whereas smallconductance Ca 2ϩ -activated K ϩ (SK) channels and K V channels are responsible for the slow afterhyperpolarization (16, 20, 56) . The resting membrane potential and action potential frequency are considered to be regulated by K ATP , BK, and K V channels (7, 16, 19, 46, 47, 56) . However, there remains a substantial gap in our knowledge regarding the cellular and functional roles, expression, and regulation of different subtypes of K ϩ channels in DSM. Of all ion channels that control DSM excitability, the K V channels are the most diverse superfamily (45, 60) . These channels have been identified in many different types of smooth muscle (5, 50, 53) , including DSM (9, 13, 56) . The expression of K V 2.1 and K V 2.2 channels has been demonstrated in rat DSM (9, 17, 41) . Expression of K V 1 channels has been shown in human DSM (13) and of K V 2.1, K V 5.1, K V 6.1, K V 6.2, and K V 6.3 subunits in mouse DSM (14, 56) .
The structural diversity of the K V channels contributes to the variety of their biophysical and pharmacological properties and makes them potentially attractive targets for pharmacological treatment of diseases such as overactive bladder (OAB) and urinary incontinence (UI) (3, 9, 45, 60) . Further investigation in this area may lead to development of selective pharmacological or genetic therapies for OAB and UI.
In the human genome, the members of the K V superfamily are encoded by 40 genes and comprise 12 K V channel families (45, 60) . Only K V 1-K V 4, K V 7, K V 11 (also known as hERG), and K V 12 (also known as elk) channel families form poreconducting channels, homo-or heterotetramers, whereas the other members of the K V families, K V 5.1, K V 6.1-6.4, K V 8.1-8.2, and K V 9.1-K V 9.3, are electrically silent and do not form functional channels when expressed alone (8, 36, 42, 44, 45, 54, 55) . Instead, they coassemble with K V 2 family, thus increasing K V channel diversity (45, 52, 60) . Those channels form heterotetrameric channels with K V 2 subunits, and their activation, deactivation, inactivation, and recovery from inactivation properties differ from those reported for homotetrameric K V 2 channels (8, 36, 42, 44, 51, 52) . For example, the K V 9.3 subunit causes an important alteration of the channel biophysical properties and increases the single-channel conductance of the heterotetrameric K V 2.1 channel (44) . This modulatory K V subunit combines with K V 2.1 to form a functional heterotetrameric K V 2.1/9.3 channel consisting of three K V 2.1 subunits and one K V 9.3 subunit (33) . Expression of the electrically silent K V 6.3 and K V 9.3 subunit has been reported in vascular smooth muscle cells (4, 12, 23, 38 -40, 43, 44, 49, 58, 59, 61). It is suggested that the heterotetrameric K V 2.1/9.3 channel contributes to the excitability in oxygen-sensitive pulmonary myocytes, and it is involved in hypoxic pulmonary vasoconstriction (44) . Structural, biophysical, and pharmacological properties of the heterotetrameric K V 2.1/silent K V channels have been extensively studied (14, 32-34, 40, 44) , but their physiological roles in smooth muscle cells, including DSM cells, remain unclear.
In the past, the study of K V channels' function has been hampered by the lack of selective inhibitors. Stromatoxin-1 (ScTx1), a spider venom peptide isolated from the African tarantula (Stromatopelma calceata), was recently identified as a highly selective inhibitor of the K V 2.1, K V 2.2, and K V 4.2 homotetramers as well as the K V 2.1/6.3 and K V 2.1/9.3 heterotetramers (14, 15, 40) . Studies in neurons, cerebral arteries, urethra, and DSM have confirmed that ScTx1 is a useful pharmacological tool to study the functional role of these K V channels (1, 6, 9, 37, 40, 61) .
The aim of this study was to examine the expression and function of K V 2.1 and electrically silent K V subunits in guinea pig DSM excitability and contractility. We applied a multidisciplinary approach to this investigation, using molecular biological techniques, patch-clamp electrophysiology, isometric tension recordings of isolated guinea pig DSM strips, and pharmacological protocols using ScTx1.
MATERIALS AND METHODS
Animal care and tissue collection. All animal studies were reviewed and approved by the University of South Carolina Institutional Animal Care and Use Committee and carried out in accordance with the Animal Use Protocol 1747. Eighty-five adult Harley albino guinea pigs (Charles River Laboratories) were used in this study (54 males and 31 females, average weight 372.8 Ϯ 2.1 g). Guinea pigs were euthanized with CO 2, followed by thoracotomy. The urinary bladder was quickly removed and placed in an ice-cold, Ca 2ϩ -free dissection solution (see Solutions and drugs) or in RNAlater solution (Qiagen, Hilden, Germany) for the RT-PCR experiments. The urinary bladder was then cut open, the entire mucosal and urothelium layers were carefully removed, and only the smooth muscle tissue from the detrusor was used. For RT-PCR and Western blot experiments, the guinea pig brains were also removed and placed in RNAlater solution.
DSM single-cell isolation. DSM single cells for RT-PCR, immunocytochemistry, and electrophysiology were freshly isolated and collected as previously described (7, 9, 10, 31) . Briefly, isolated DSM was cut in strips (5-8 mm long, 2-4 mm wide), and 1-2 strips were placed in dissection solution (2 ml) supplemented with 1 mg/ml bovine serum albumin (BSA), 1 mg/ml papain (Worthington Biochemical, Lakewood, NJ), and 1 mg/ml DL-dithiothreitol and incubated for 25-30 min at 37°C. The DSM strips were transferred to dissection solution (2 ml) containing 1 mg/ml BSA, 1 mg/ml collagenase (type II from Sigma-Aldrich, St. Louis, MO), and 100 M CaCl2 and incubated for 5-6 min at 37°C. DSM strips were then washed with fresh BSA-containing dissection solution. The individual DSM cells were dispersed when the enzyme-treated tissue was passed through the tip of a Pasteur pipette and then used for electrophysiology, RT-PCR, and immunocytochemistry studies. DSM cells for patch-clamp experiments were stored at 4°C for further use.
RNA extraction, RT-PCR, and sequencing. For RT-PCR experiments, whole DSM tissue and freshly isolated single DSM cells were immediately used for RNA extraction. RT-PCR experiments were conducted as previously described, and the single-cell RT-PCR experiments were carefully controlled for contaminations from non-DSM cells (9, 10) . Specific primers for KV2.1, KV2.2, KV4.2, KV5.1, KV6.1-6.3, KV8.1-8.2, and KV9.1-9.3 were designed based on the sequences of multiple species present in GenBank and aligned using Primer Premier 5 software (PREMIER Biosoft International, Palo Alto, CA). Specific primer pair sequences are listed in Table 1 . The cDNA production was amplified using GoTaq green master mix (Promega) and specific primers for KV channel subunits. The PCR annealing temperature for each primer pair was optimized using a Mastercycler gradient thermocycler (Eppendorf, Hamburg, Germany). Negative control experiments for PCR were performed in the absence of the reverse transcriptase (ϪRT). Guinea pig brain tissue, which is known to express the studied KV channels, was used as a positive control. PCR products were purified using the GenElute PCR clean-up kit (Sigma-Aldrich) and sequenced at the University of South Carolina Environmental Genomics Facility for sequence confirmation.
Western blot analysis. Protein extraction and Western blot analysis were performed as previously described (9, 10) . The blots were incubated with the affinity-purified rabbit polyclonal primary antibodies anti-KV2.1 (DRK1, 1:400), anti-KV2.2 (CDRK, 1:2,000), and anti-KV4.2 (Kcnd2, 1:200; Alomone Labs, Jerusalem, Israel) overnight at 4°C. The membrane was then incubated with goat anti-rabbit IgG conjugated with horseradish peroxidase diluted to 1:3,000 in the blocking buffer for 1 h at room temperature. Bound antibodies were detected using an ECL substrate kit (Amersham, Piscataway, NJ) according to the manufacturer's instructions. Staining specificity was verified by preincubation of the antibodies with a competing peptide.
Immunocytochemistry. Immunocytochemistry was performed as previously described (9, 10) . DSM cells were incubated with the rabbit polyclonal primary antibodies anti-KV2.1, anti-KV2.2, and anti-KV4.2 (DRK1, CDRK, and Kcnd2, 1:100; Alomone Labs) at 37°C for 1 h. Next, cells were labeled with secondary antibodies (Cy3-conjugated anti-rabbit IgG, 1:200 in PBS/3% normal donkey serum/0.01% Triton X-100; Jackson ImmunoResearch, West Grove, PA) for 1 h in a dark room. After labeling, DSM cells were washed with PBS and incubated with phalloidin for 2 h in the dark. Cells were then washed two more times, incubated with 4=,6-diamidino-2-phenylindole for 15 min and washed again, and then mounted onto slides with DABCO (1,4-diazabicyclo-2-2-2-octane). Control treatments were carried out as follows: 1) omission of the primary antibody for confirming the specificity of the secondary antibody and 2) absorption of the primary antibody by a competing peptide for confirming the specificity of the primary antibody. Images at ϫ63 magnification were acquired with an LSM 510 META confocal microscope (Carl Zeiss, Göttingen, Germany). The slides for each group were imaged with the same laser power, gain settings, and pinhole for the controls and antibody treatment.
Electrophysiological patch-clamp recordings. To preserve the physiological environment of the DSM cells, the whole cell perforated patch-clamp technique was applied in all electrophysiological experiments (18, 29) . Freshly isolated DSM cells were used for patchclamp experiments within 12 h after isolation. Isolated DSM cells were placed in an experimental chamber for at least 20 min to allow them to adhere to the glass bottom and were then washed with extracellular solution (see Solutions and drugs). Only DSM cells with a spindle shape, bright appearance, and well-defined cell edges were used. The ionic currents were recorded using an Axopatch 200B amplifier, Digidata 1440A, and pCLAMP 10.2 software (Molecular Devices, Sunnyvale, CA) and then filtered using an eight-pole Bessel filter 900CT/9L8L (Molecular Devices). The glass pipettes used for the patch-clamp experiments were made from borosilicate glass (Sutter Instruments, Novato, CA) and pulled using a Narishige PP-830 vertical puller (Narishige Group, Tokyo, Japan). The pipettes were polished with a Micro Forge MF-830 fire polisher (Narishige Group) and coated with dental wax to reduce capacitance.
In all voltage-clamp experiments, the BK channel was blocked with 100 nM paxilline, a BK channel-selective inhibitor. To study the K V currents, we applied various voltage-step protocols. The leak current was not subtracted during the experiments. The average current value during the last 50 ms of the 400-ms depolarization step was taken for the KV current. For the controls, current traces of at least 5 pulses within 10 min were recorded and averaged. Only cells with stable control currents in response to depolarization steps within at least 10 min were used to study ScTx1 effects. All patch-clamp experiments were carried out at room temperature.
Isometric DSM tension recordings. Isometric tension recordings of guinea pig DSM isolated strips were performed as previously described (7, 9, 31) . Briefly, small DSM muscle strips (5-8 mm long, 2-3 mm wide) were placed between a stationary mount and a force-displacement transducer in thermostatically controlled (at 37°C) 10-ml tissue baths filled with Ca 2ϩ -containing physiological salt solution (see Solutions and drugs). Strips were stretched to 1 g of tension and were then washed every 15 min during an equilibration period of 45-60 min. Electrical field stimulation (EFS) was generated using a PHM-152I stimulator (Med Associates, Georgia, VT). DSM contractile responses were recorded using MyoMed software (Med Associates).
Solutions and drugs. The Ca 2ϩ -free dissection solution had the following composition (in mM): 80 monosodium glutamate, 55 NaCl, 6 KCl, 10 glucose, 10 HEPES, and 2 MgCl2, pH 7.3, adjusted with NaOH. The Ca 2ϩ -containing physiological salt solution was prepared daily and contained (in mM) 119 NaCl, 4.7 KCl, 24 NaHCO3, 1.2 KH2PO4, 2.5 CaCl2, 1.2 MgSO4, and 11 glucose and was aerated with 95% O2-5% CO2 to obtain pH 7.4. The extracellular solution used in the electrophysiological experiments contained (in mM) 134 NaCl, 6 KCl, 1 MgCl2, 2 CaCl2, 10 glucose, and 10 HEPES; pH was adjusted to 7.4 with NaOH. The pipette solution contained (in mM) 110 potassium aspartate, 30 KCl, 10 NaCl, 1 MgCl2, 10 HEPES, and 0.05 EGTA, pH adjusted to 7.2 with NaOH, and was supplemented with freshly dissolved 200 g/ml amphotericin-B. ScTx1 was purchased from Alomone Labs. DL-Dithiothreitol, paxilline, tetrodotoxin (TTX), carbachol, and collagenase type II were obtained from Sigma-Aldrich.
BSA and amphotericin-B were obtained from Fisher Scientific. Papain was obtained from Worthington Biochemical.
Data analysis and statistics. Clampfit version 10.2 software (Molecular Devices) was used for electrophysiological data analyses, MiniAnalysis software (Synaptosoft, Decatur, GA) was used for data analyses of DSM contraction, and GraphPad Prism 4.03 software (GraphPad Software, La Jolla, CA) was used for statistical analyses. For data presentation, CorelDraw Graphic Suite X3 software (Corel, Ottawa, ON, Canada) was used. Results are summarized as means Ϯ SE for the number of DSM strips or cells (n) and the number of guinea pigs (N). Data were compared using ANOVA or paired Student's t-test. P values Ͻ0.05 were considered statistically significant.
RESULTS

RT-PCR.
RT-PCR experiments were conducted in both whole DSM tissues and freshly isolated single DSM cells to determine the expression of mRNA messages for the subunits of the known ScTx1-sensitive K V channels (K V 2.1, K V 2.2, and K V 4.2) as well as all K V silent subunits (K V 5.1, K V 6.1-6.3, K V 8.1-8.2, and K V 9.1-9.3) that associate with the K V 2 family. The expression of mRNA message for all these K V channel subunits was detected in guinea pig brain, which was used as a positive control (Fig. 1) . However, the whole DSM tissue expressed detectible mRNA messages for K V 2.1, K V 6.2, K V 6.3, K V 8.2, and K V 9.1-9.3 but not for K V 2.2, K V 4.2, K V 5.1, K V 6.1, and K V 8.1 channel subunits (Fig. 1) . The presence of other cell types within the DSM layer, such as neurons, fibroblasts, and vascular myocytes, may lead to the detection of K V channel subunits expressed in cell types other than DSM cells. To eliminate the possible contamination from other cell types, we applied single-cell RT-PCR experiments to freshly isolated DSM cells. Again, the single-cell RT-PCR confirmed the expression of mRNA messages for K V 2.1, K V 6.2, K V 6.3, K V 8.2, and K V 9.1-9.3 but not for K V 2.2, K V 4.2, K V 5.1, K V 6.1, and K V 8.1 subunits (Fig. 1) . A lack of genomic DNA contamination in mRNA isolated from single DSM cells was also confirmed by using the negative control reactions lacking the reverse transcriptase. All purified PCR products were sequenced to confirm their identity. Results were verified in 18 different preparations, obtained from 16 guinea pigs. We next applied Western blot analysis and immunocytochemistry to detect whether proteins for the three main channel subunits that can form their own homotetramers (K V 2.1, K V 2.2, and K V 4.2) are expressed in DSM.
Western blot analysis. Using commercial K V channel subunit-specific antibodies, we confirmed protein expression of K V 2.1 subunit in whole DSM tissue with Western blot experiments (Fig. 2) . Preabsorption of the primary antibody with its antigenic competing peptide indicated the specificity of the antibodies for their intended epitope. Consistent with our RT-PCR data, no K V 2.2 and K V 4.2 proteins were detected in whole DSM tissue (data not shown). The protein expression for each separate K V channel subunit was verified in three separate Western blot reactions using proteins isolated from three guinea pigs.
Immunocytochemistry. To further verify the presence of K V 2.1 channel subunits in guinea pig DSM, we immunocytochemically labeled freshly isolated DSM cells. Freshly isolated DSM cells had bright, distinct edges under phase-contrast optics. Anti-K V 2.1 antibody specifically labeled the freshly isolated cells (Fig. 3) . However, immunofluorescence staining was not detected for K V 2.2 and K V 4.2 channel subunits in isolated DSM cells (data not shown), which is consistent with our RT-PCR and Western blot experiments. The immunocytochemical experiments were carefully controlled for specificity by the omission of the primary antibody or absorption of the primary antibody by a competing peptide (Fig. 3) . Results were verified in eight cells, obtained from three guinea pigs.
Voltage dependence and ScTx1 sensitivity of guinea pig DSM whole cell K V current. All voltage-clamp experiments were conducted in the presence of 100 nM paxilline to eliminate the contribution of the BK channels to the total whole cell current and to study the remaining K V current. The average DSM cell capacitance was 28.2 Ϯ 1.2 pF (n ϭ 155 cells; N ϭ 61 guinea pigs). In the first experimental series, we applied a 400-ms voltage-step protocol, illustrated in Fig. 4A . A series of potentials between Ϫ70 and ϩ60 mV were applied from a holding potential (V h ) of Ϫ70 mV in 10-mV increments, and then cells were repolarized to Ϫ40 mV for another 800 ms. The K V current amplitude increased steeply with increasing the membrane potential, and small deactivating tail currents were recorded on repolarization to Ϫ40 mV (Fig. 4A ). Application of ScTx1 (100 nM) caused a significant inhibition of the whole cell K V current amplitude (n ϭ 12; N ϭ 9; P Ͻ 0.05; Fig. 4 ). The remaining ScTx1-insensitive current is possibly determined by other types of K V channels. The inhibitory effect of ScTx1 (100 nM) on the current-voltage relationship in guinea pig DSM cells is shown in Fig. 4B (n ϭ 12; N ϭ 9; P Ͻ 0.05). Table 1 . No products were observed in the negative controls in which reverse transcriptase (RT) was left out of the reaction. Guinea pig brain tissue was used as a positive control.
In the second experimental series, a long-lasting doublepulse protocol was applied (Fig. 5A) . The cell membrane potential was stepped from a V h of Ϫ70 mV to potentials between Ϫ120 and ϩ40 mV for 15 s, before stepping to ϩ60 mV for 250 ms to determine the current availability at the end of each presiding step. As is evident from Fig. 5A , the K V currents at various voltages showed a slow pattern of inactivation. Typical current traces of K V current elicited by this protocol before and after application of 100 nM ScTx1 are shown in Fig. 5A (n ϭ 7; N ϭ 5).
Effects of ScTx1 on the steady-state activation and inactivation of the K V current. We examined whether ScTx1 (100 nM) can shift the steady-state activation and inactivation curves of the K V current. Voltage-dependent activation and inactivation of ScTx1-sensitive current was studied with the voltage protocols shown in Figs. 4A and 5A, respectively. Activation curves of the K V current in the presence or absence of 100 nM ScTx1 (Fig. 4C) were obtained from the tail currents recorded after stepping back to Ϫ40 mV (Fig. 4A) . The activation curves are plotted as normalized conductance (G/G max ) against voltage and are fitted using a single-component Boltzmann equation (Fig. 4C) . ScTx1 (100 nM) did not significantly affect the half-maximal activation potential (V 0.5 ) of the steady-state activation. The V 0.5 was Ϫ11.7 Ϯ 0.8 mV in the absence of ScTx1 and Ϫ14.5 Ϯ 2.2 mV in the presence of 100 nM ScTx1 ( Fig. 4B ; Table 2 ). The slope factor (k) of the steady-state activation curve remained unchanged by 100 nM ScTx1, and it was 10.1 Ϯ 0.8 mV under control conditions and 11.5 Ϯ 2.0 mV in the presence of 100 nM ScTx1 (Fig. 4B) .
We next evaluated the effect of ScTx1 (100 nM) on the steady-state inactivation curve. Using the protocol shown in Fig. 5A , steady-state inactivation curves were obtained from the maximum value of the normalized end-pulse current amplitudes (I/I max ) recorded at ϩ60 mV and plotted against test potentials. K V current steady-state inactivation curves in the presence and absence of 100 nM ScTx1, fitted by a singlecomponent Boltzmann equation, are shown in Fig. 5B . There was no significant difference in the V 0.5 , which was Ϫ63.6 Ϯ 1.7 mV in the absence of ScTx1 and Ϫ65.3 Ϯ 1.7 mV in the presence of 100 nM ScTx1 (n ϭ 7; N ϭ 5; P Ͼ 0.05; Fig. 5B ). This V 0.5 value is consistent with data from mouse DSM cells (56) . The slope factor k of the steady-state inactivation curves also remained unchanged, and it was Ϫ24.5 Ϯ 1.7 mV under control conditions and Ϫ22.1 Ϯ 1.8 mV in the presence of 100 nM ScTx1 (n ϭ 7; N ϭ 5; P Ͼ 0.05; Fig. 5B ). We also found that the total K V current of guinea pig DSM cells did not completely inactivate (Fig. 5B) .
The ScTx1-sensitive current was evaluated after subtraction from the total K V current and the remaining current after application of 100 nM ScTx1 (Figs. 4 and 5 ). All parameters of the ScTx1-sensitive current were elucidated and are shown in Tables 2 and 3 . The half-maximal activation of the ScTx1 current was V 0.5 ϭ Ϫ6.9 Ϯ 1.4 mV, and the slope factor k was 10.2 Ϯ 1.2 mV (Fig. 4C) . The half-maximal steady-state inactivation was V 0.5 ϭ Ϫ50.1 Ϯ 3.7 mV, and the slope factor k was Ϫ23.4 Ϯ 3.9 mV (n ϭ 7; N ϭ 5; P Ͼ 0.05; Fig. 5B) . Comparisons of the steady-state activation and inactivation parameters of the ScTx1-sensitive current are shown in Table  2 . Table 2 also presents published data on homotetrameric K V 2.1 and heterotetrameric K V 2.1/silent K V channels in heterologous expression systems and native tissues such as neurons, arterial and urethral smooth muscle, and mouse DSM. Most importantly, as shown in Table 2 , the steady-state properties of the ScTx1-sensitive K V current correspond to a channel population of homotetrameric K V 2.1 and heterotetrameric K V 2.1/silent K V channels. ScTx1 affects the kinetics of K V current activation. We investigated the effect of 100 nM ScTx1 on the time constants of activation (-activation) and inactivation (-inactivation) of the K V current. Figure 6A shows representative K V current traces evoked by depolarization steps to ϩ40 mV (400 ms), which is close to the peak of the action potential in DSM. The data analysis showed that ScTx1 (100 nM) decreased the time constant of total outward current activation at ϩ40 mV from 25.5 Ϯ 2.1 to 23.7 Ϯ 1.2 ms (n ϭ 12; N ϭ 9; P Ͻ 0.05; Fig.  6A ). The time constant of activation of the ScTx1-sensitive current was 35.3 Ϯ 3.6 ms at ϩ40 mV (Fig. 6B) .
The time constant of inactivation was determined using the stimulation protocol shown in Fig. 5A . ScTx1 did not affect the kinetics of inactivation of K V current. The time constant of inactivation was 5.4 Ϯ 0.8 s in the absence of ScTx1 and 5.4 Ϯ 1.3 s in the presence of 100 nM ScTx1 at ϩ40 mV (n ϭ 7; N ϭ 5; P Ͼ 0.05; Fig. 6B ). The time constant of inactivation of the subtracted ScTx1-sensitive current was 5.9 Ϯ 1.6 s at ϩ40 mV (Fig. 6B) .
Collectively, our findings indicate that at positive voltages, ScTx1 has a statistically significant effect on the kinetics of the K V current activation. The time constants of activation and inactivation of the ScTx1-sensitive current obtained experimentally in our study compared with published data on homotetrameric K V 2.1 and heterotetrameric K V 2.1/silent K V channels are summarized in Table 3 .
ScTx1 does not affect the resting membrane potential in guinea pig DSM cells. We used the amphotericin-perforated, current-clamp mode of the patch-clamp technique to test the effect of ScTx1 on the resting membrane potential in guinea pig DSM cells in the absence of paxilline. In current-clamp mode, we recorded at least 7-10 min of stable control before applying 100 nM ScTx1 for another 10 min. ScTx1 (100 nM) did not affect the resting membrane potential. The values of the resting membrane potential were Ϫ32.2 Ϯ 2.3 mV under control conditions and Ϫ32.9 Ϯ 3.2 mV in the presence of 100 nM ScTx1 (n ϭ 10; N ϭ 6; P Ͼ 0.05).
ScTx1 increases spontaneous and nerve-evoked contractions of isolated DSM strips. We studied the effect of ScTx1 on physiologically relevant spontaneous (myogenic) phasic and tonic contractions of guinea pig DSM isolated strips. To minimize any possible effects caused by neurotransmitter release, we performed all experiments with the exception of the EFS-induced contractions in the presence of 1 M TTX, a neuronal Na ϩ channel blocker. DSM strips were preincubated with 1 M TTX before the experiments. Isometric DSM tension recordings of isolated guinea pig DSM strips showed that ScTx1 (100 nM) increased spontaneous phasic contraction Fig. 4 . Voltage-dependent activation of stromatoxin-1 (ScTx1)-sensitive KV currents in guinea pig DSM cells. A: representative recording of the effect of ScTx1 on the whole cell KV current elicited by a short (400 ms) voltage-step protocol (top). ScTx1 (100 nM) significantly decreased the voltage step-induced whole cell KV current. ScTx1-sensitive current was obtained after subtraction of the remaining whole cell current from the control current. The scale bar applies to all recordings. B: the current-voltage relations show that ScTx1 (100 nM) decreased voltage-dependent whole cell KV current in guinea pig DSM cells (n ϭ 12; N ϭ 9). *P Ͻ 0.05; **P Ͻ 0.005; ***P Ͻ 0.001. The current-voltage relation of the subtracted ScTx1-sensitive current is also shown. C: steady-state activation curves of the KV current in the absence (control) or presence of 100 nM ScTx1 (ScTx1-insensitive current). Data were obtained from the current recordings shown in A. The tail currents recorded after stepping back to Ϫ40 mV for 800 ms were used to build the normalized conductance (G/Gmax) curve. The curves were fitted using a single-component Boltzmann equation. The steady-state activation curve of the ScTx1-sensitive current is also shown. Values are means Ϯ SE. All experiments were performed in the presence of the selective BK channel inhibitor paxilline (100 nM).
amplitude, muscle force integral (area under the curve), and muscle tone without any effect on the phasic contraction frequency (n ϭ 13; N ϭ 7; P Ͻ 0.05; Fig. 7 ). Both ScTx1-induced and spontaneous phasic contractions were completely inhibited by 1 M nifedipine, a selective blocker of the L-type voltage-gated Ca 2ϩ channels (n ϭ 4, N ϭ 4). In the next experimental series, we studied the effect of ScTx1 on DSM contractions under conditions of sustained membrane depolarization, induced by either 20 mM KCl or 1 M carbachol. ScTx1 (100 nM) slightly increased only the carbachol-induced phasic contraction amplitude (n ϭ 9; N ϭ 9; P Ͻ 0.05; Fig. 8 ; Table 4 ) but had no effect on any other parameters of the DSM contractions induced by 1 M carbachol (n ϭ 9; N ϭ 9; P Ͼ 0.05; Fig. 8; Table 4 ) or 20 mM KCl (n ϭ 12; N ϭ 10; P Ͼ 0.05; Fig. 8 ; Table 4 ). After application of ScTx1 (100 nM), nifedipine (1 M) completely inhibited the DSM contractility of strips precontracted with 1 M carbachol (n ϭ 8; N ϭ 7) or 20 mM KCl (n ϭ 4; N ϭ 4).
Our next goal was to investigate whether ScTx1-sensitive K V channels modulate the nerve-evoked (EFS-induced) contractions of guinea pig DSM. These experiments were conducted in the absence of TTX. Figure 9 shows original EFSinduced DSM contraction recordings and EFS frequency-response curves created by measuring the amplitude of the EFS-induced contraction at stimulation frequencies of 5, 7.5, 10, 12.5, 15, 20, 30, 40, and 50 Hz. An initial EFS frequencyresponse curve was generated under control conditions, and then DSM strips were preincubated for 30 min with 100 nM ScTx1. After this procedure, a second EFS frequency-response curve was generated using the same EFS parameters as indi- cated above. The results showed that EFS frequency-responses of guinea pig DSM strips were significantly increased in the presence of 100 nM ScTx1 at all stimulation frequencies (n ϭ 6; N ϭ 5; P Ͻ 0.05; Fig. 9 ). To confirm the stability of the guinea pig DSM strips, we also performed time controls by generating two consecutive EFS frequency-response curves in a 30-min interval without applying ScTx1. There was no statistically significant difference between the two EFS frequency-response curves in the absence of ScTx1 (n ϭ 4; N ϭ 4; P Ͼ 0.05). The EFS experiments suggest that ScTx1-sensitive K V channels also work to oppose the nerve-evoked contractions in guinea pig DSM.
DISCUSSION
In this study, we revealed that K V 2.1-containing channels are physiologically relevant regulators of guinea pig DSM excitability and contractility. On the basis of our data obtained from molecular biology, patch-clamp, and functional studies on DSM contractility, we can draw three important conclusions. First, K V 2.1 and several silent K V channel subunits (K V 6.2-6.3, K V 8.2, and K V 9.1-9.3) are expressed in guinea pig DSM. Second, ScTx1-sensitive K V channels contribute to the total K V current in isolated DSM cells. Third, ScTx1-sensitive K V channels regulate DSM contractility by opposing both myogenic and nerve-evoked contractions.
In a recent article (9), we reported that ScTx1-sensitive K V channels are expressed and functional in rat DSM. We have since extended our study and hypothesized that a whole population of ScTx1-sensitive K V 2.1-containing channels assembled by various silent K V channel subunits are key regulators of DSM excitability and contractility of guinea pig DSM. To test this hypothesis, we applied a multitechnique molecular biology approach to elucidate the presence of all known ScTx1-sensitive K V channels in guinea pig DSM. The RT-PCR experiments showed mRNA expression of K V 2.1, K V 6.2-6.3, K V 8.2, and K V 9.1-9.3 in both whole DSM tissue and single DSM cells and ruled out the expression of two other ScTx1-sensitive channels, the K V 2.2 and K V 4.2 homotetramers, along with K V 5.1, K V 6.1, K V 8.1 silent subunits (Fig. 1) . Using Western blot and immunocytochemistry, we confirmed the expression of the K V 2.1 channel protein in guinea pig DSM (Figs. 2 and 3) . Therefore, the ScTx1-sensitive K V current in guinea pig DSM cells is determined by K V 2.1-containing channels. Consistent with our findings, the K V 2.1 subunit has been reported to be the major K V subunit in rat and mouse DSM (9, 17, 41, 56) . From the electrically silent subunits that we identified (K V 6.2-6.3, K V 8.2, and K V 9.1-9.3), only K V 6.3 and K V 9.3 have been reported to contribute to the ScTx1-sensitive current by forming K V 2.1/6.3 and K V 2.1/9.3 ScTx1-sensitive K V heterotetramers (14, 15, 40) . It is also well known that the K V 9.3 subunit combines only with the K V 2.1 subunit to form a functional heterotetramer and remains electrically silent if expressed alone in artificial systems (14, 32-34, 44, 45) . Although ScTx1 sensitivity has not yet been reported for all combinations of K V 2.1 and K V silent subunits, the most plausible assumption is that all heterotetrameric K V 2.1/K V silent subunits will be ScTx1-sensitive, since the K V 2 subunit must be part of the channel.
Using the amphotericin-perforated patch-clamp technique, we investigated the properties of the guinea pig DSM K V current under conditions of paxilline-blocked BK current, which is the main voltage-dependent K ϩ current in DSM cells (7, 25, 46, 48) . The application of 100 nM ScTx1 inhibited ϳ22% (at 0 mV) of the remaining K V current amplitude in guinea pig DSM cells (Fig. 4) . Most likely, the residual ScTx1-insensitive current is encoded by other types of K V channels. Also, ScTx1 affected the K V current time constant of activation (Fig. 6A) .
Our molecular biology studies did not detect the expression of K V 2.2 or K V 4.2 channel subunits (Fig. 1) , and therefore we Values are means Ϯ SE of half-maximal potentials (V0.5) of steady-state activation and inactivation from our experiments in guinea pig detrusor smooth muscle (DSM), as well as data from the literature for currents in other species and for homotetrameric KV2.1 and heterotetrameric KV2.1/silent KV channel currents. NA, not available.
excluded those channels as possible candidates determining the observed ScTx1-sensitive K V current in guinea pig DSM. Because we identified the mRNA expression of only K V 2.1 and electrically silent K V channel subunits, we hypothesized that the ScTx1-sensitive K V current could be attributed to homotetrameric K V 2.1 channels and/or heterotetrameric K V 2.1/silent K V channels. Our detailed analyses of the biophysical properties of the ScTx1-sensitive K V current in guinea pig DSM demonstrate substantial similarities to those reported for heterotetrameric K V 2.1/silent K V channels (Tables 2 and 3 ). Specifically, our data indicate that the V 0.5 of the steady-state inactivation of the ScTx1-senstitive current was about Ϫ50 mV, which is more negative than the reported values for homotetrameric K V 2.1 channels and consistent with the reported values for heterotetrameric K V 2.1/silent K V channels (Table 2 ). In addition, this V 0.5 value of Ϫ50 mV is consistent with the recently reported V 0.5 for the ScTx1-sensitive current in smooth muscle cells isolated from rabbit urethra (37) . Therefore, heterotetrameric assembly of K V 2.1 and silent K V channel subunits accounts for the ScTx1-sensitive inhibition of the K V current in guinea pig DSM. Although we do not exclude the possible involvement of the K V 2.1 homotetrameric channel, we assume that a population of heterotetrameric K V 2.1/silent K V channels most likely underlies the K V current in guinea pig DSM because all these silent subunits cannot form functional channels and associate only The subtracted ScTx1-sensitive current is also shown. Bar graphs show the time constants of activation of the control current, ScTx1-insensitive current, and ScTx1-sensitive current at 0 and ϩ40 mV. ScTx1 decreased significantly the time constant of activation at ϩ40 mV (n ϭ 12; N ϭ 9). *P Ͻ 0.05. B: ScTx1 (100 nM) did not affect time constant kinetics of inactivation of KV current elicited by a voltage-step depolarization to ϩ40 mV (protocol as shown in Fig. 5A ; n ϭ 7; N ϭ 5; P Ͼ 0.05). Values are means Ϯ SE. All experiments were performed in the presence of the selective BK channel inhibitor paxilline (100 nM).
with the K V 2 family. This assumption is also supported by findings of Thorneloe and Nelson (56) suggesting that K V 2.1 does not form its own homotetramer in mouse DSM. They further suggest that in mouse DSM, K V 2.1 can potentially coassemble with K V 5.1 and K V 6 subunits (56) . In the present study, however, we did not find K V 5.1 or K V 6.1 subunit but confirmed the expression of K V 6.2-6.3 subunits (Fig. 1) . This may be due to species differences. We have also further identified the expression of K V 8.2 and K V 9.1-9.3 silent subunits in guinea pig DSM cells (Fig. 1) .
It has been suggested that K V 2.1/9.3 heterotetramer contributes to the excitability in pulmonary and cerebral arteries (1, 44, 61) . We observed in current-clamp mode that ScTx1 did not affect the cell resting membrane potential of guinea pig DSM cells. Analysis of steady-state activation and inactivation properties of the K V channels (Figs. 4 and 5) showed that the ScTx1-sensitive channels are likely active at voltages close to the level of the recorded resting membrane potential in guinea pig DSM cells (approximately Ϫ32 mV), although their activity at these voltages was relatively low based on the steadystate activation curve. The lack of ScTx1 effect of the resting membrane potential could be explained by the relatively minor contribution of the ScTx1-sensitive current to the total whole cell outward current in DSM cells, as shown in the currentvoltage relationship in Fig. 4B . Furthermore, our voltageclamp experiments were performed in the presence of paxilline to eliminate the BK channel, which is the main contributor to Values are means Ϯ SE of the time constants () of activation and inactivation (with action potential given in parentheses) from our experiments in guinea pig DSM, as well as data from the literature for homotetrameric KV2.1 and heterotetrameric KV2.1/silent KV channel currents. Fig. 7 . ScTx1 increases spontaneous phasic contraction amplitude, muscle force integral, and muscle tone in guinea pig DSM strips. A: representative original trace of spontaneous phasic DSM contractions and the effect of 100 nM ScTx1. B: summary data showing a statistically significant increase in DSM spontaneous phasic contraction amplitude, muscle force integral, and muscle tone. For comparison of the phasic contraction parameters of the DSM strips, data were normalized to the spontaneous contractions, which were taken to be 100%, and then expressed as percentages. DSM force is presented as muscle force integral and was determined by integrating the area under the curve of the phasic contractions component. The tone of the DSM strips was determined by measuring the phasic contraction baseline curve. To evaluate the effect of the ScTx1 on the phasic contractions, we analyzed a 5-min period before ScTx1 application for the controls and another 5-min period 30 min after ScTx1 application (100 nM). Values are means Ϯ SE (n ϭ 13; N ϭ 7). *P Ͻ 0.05; **P Ͻ 0.01. Tetrodotoxin (1 M) was present throughout the experiments. the total whole cell outward current in DSM cells (30, 31, 48) , whereas the current-clamp recordings were performed in the absence of paxilline with physiologically active BK channels. On the basis of these results, we conclude that under physiological conditions, ScTx1-sensitive channels are not the main contributors to setting the resting membrane potential in guinea pig DSM cells. However, they regulate excitability at more positive potentials, during the peak of an action potential (Fig.  4) . Consistently, Hayase et al. (24) reported no effect of ScTx1 on the resting membrane potential in mouse DSM recorded by intracellular microelectrodes. Our data support the hypothesis that K V 2.1-containing channels most likely control the repolarization phase of the action potential and perhaps also the slow afterhyperpolarization in guinea pig DSM.
In the bladder filling phase, spontaneous contractions do not increase substantially intravesical pressure and thus do not initiate voiding (2, 3, 28) . During bladder filling, spontaneous contractions occur locally and do not spread throughout the tissue, probably due to a weak electrical coupling between the DSM cells (21, 22) . Voiding contractions occur after excitation of the parasympathetic nerves, which causes synchronized contraction of the whole bladder, followed by elevation of the intravesical pressure (2, 3, 26) . In guinea pig DSM, a burst of action potentials triggers a single phasic contraction (21) . Blocking the K V 2.1-containing channels with ScTx1 is expected to increase the action potential frequency within a burst of action potential, and therefore the amplitude of the phasic contraction, without any effect on the phasic contraction frequency (Fig. 7) . Our studies on DSM contractility revealed that ScTx1 significantly increased the spontaneous phasic contraction amplitude, muscle force integral, and muscle tone in isolated guinea pig DSM strips (Fig. 7) , consistent with previous findings in rat DSM (9) . However, ScTx1 had no effect on the DSM contractions induced by 1 M carbachol or 20 mM KCl with the exception of slightly increased phasic contraction amplitude in the presence of 1 M carbachol (Table 4 ; Fig. 8 ). These results demonstrate that under experimental conditions of membrane depolarization, the K V 2.1-containing channels have no further contribution to the membrane excitability and contractility (Table 4 ; Fig. 8 ). The K V 2.1-containing channels, by decreasing membrane excitability, work to oppose spontaneous contractions under physiological conditions. Our results also showed that ScTx1 significantly increased the amplitude of the EFS-induced contractions over a range of stimulation frequencies, 5-50 Hz (Fig. 9 ). This indicates that K V 2.1-containing channels, by decreasing membrane excitability, also oppose the DSM contractility in response to excitatory neurotransmitters.
Under pathological conditions, such as some forms of OAB, spontaneous myogenic contractions can also cause a rise of intravesical pressure, initiating involuntary voiding (3). These pathological conditions are poorly understood, and the current pharmacological treatment is limited to antimuscarinics that have many adverse effects (3). Our study shows that pharmacological block of K V 2.1-containing channels with ScTx1 increases DSM contractility (Figs. 7 and 9) . Therefore, genetic mutations causing K V 2.1 channel malfunction would be expected to cause DSM dysfunction. Consistently, other studies also suggest the implication of the K V 2.1 channels in OAB (17, 41) . Thus a better understanding of K V 2.1-containing channels is an important step for developing new therapeutic strategies for treatment of OAB and UI. The K V 2.1-containing channels may represent new targets for pharmacological or genetic control of OAB. Values are means Ϯ SE of %change in DSM contraction parameters under conditions of membrane depolarization induced by 1 M carbachol or 20 mM KCl (K ϩ ) in the presence of 100 nM ScTx1. Carbachol results are from 9 DSM strips obtained from 9 guinea pigs; KCl results are from 12 DSM strips obtained from 10 guinea pigs. *P Ͻ 0.05, ScTx1 slightly increased phasic contraction amplitude only under conditions of depolarization with carbachol. ScTx1 had no other statistically significant effect on DSM contraction parameters. 
